Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Downregulation of DUSP9 promotes tumor progression and contributes to poor prognosis in human colorectal cancer

PROVIDER: PRJNA659790 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12536108.fastq.gz	Fastqsanger.gz
	SRR12536109.fastq.gz	Fastqsanger.gz
	SRR12536110.fastq.gz	Fastqsanger.gz
	SRR12536111.fastq.gz	Fastqsanger.gz
	SRR12536112.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Downregulation of MGST3 promotes colorectal cancer progression

Project description:Downregulation of MGST3 promotes colorectal cancer progression

| PRJNA1400508 | ENA

Homo sapiens

Project description:A five-gene signature is associated with tumor progression and poor prognosis in colorectal cancer

| PRJNA117645 | ENA

High Expression of TMEM161A in Colorectal Cancer is Associated with Tumor Proliferation and Poor Prognosis

Project description:TMEM161A is a membrane-associated protein implicated in oxidative stress responses, but its role in colorectal cancer (CRC) has not been elucidated. We analyzed 133 CRC specimens and found that high TMEM161A expression correlated with poor prognosis. siRNA-mediated TMEM161A knockdown in CRC cell lines (HT29, LIM1215) suppressed proliferation, colony formation, and invasion, with delayed G2/M transition. RNA-seq and GSEA revealed downregulation of E2F targets, G2/M checkpoint, MYC, and mTORC1 signaling, and upregulation of p53 and TNFα–NFκB pathways. TMEM161A thus promotes CRC progression and may serve as a prognostic biomarker and therapeutic target.

2026-05-27 | GSE309797 | GEO

Single-cell RNA sequencing reveals cellular heterogeneity in lineage specification of MC38 subcutaneous tumor cells with either SPP1 overexpression or vector control

Project description:SPP1 (secreted phosphoprotein 1), also known as osteopontin, has emerged as a pivotal factor in the tumor microenvironment (TME) across various cancers. It has been reported that SPP1-positive macrophages are associated with immunosuppressive activity and poor prognosis in colorectal cancer (CRC). The increasing proportion of SPP1-positive macrophages contributes to immune suppression and immune desert by inhibiting T cell function in liver metastatic lesions. However, the role of SPP1 in colorectal cancer liver metastasis (CRLM) remains incompletely understood. Therefore, the impact of tumor-secreted SPP1 on the CRC microenvironment warrants further investigation. To explore the effect of SPP1 on diverse TME cell populations, we conducted single-cell RNA sequencing on MC38 xenografts. Our results revealed an increase in fibroblasts and a concurrent decrease in T cells following SPP1 overexpression, suggesting that SPP1 promotes cancer-associated fibroblast (CAF) infiltration into the CRC TME.

2025-09-24 | GSE298348 | GEO

TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages

Project description:Poor prognosis colorectal cancer (CRC) is linked to a TGF-β-activated tumor microenvironment that suppresses immune responses. Inhibiting TGF-β signaling promotes T cell infiltration and enhances immune checkpoint blockade effectiveness, highlighting a network of genetic programs that prevent effective immune responses and clonal expansion of T cells, ultimately enabling metastatic growth.

2025-07-25 | GSE273148 | GEO

BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins

Project description:Colorectal cancer (CRC) is the third most commonly diagnosed cancer, which despite recent advances in treatment, remains incurable due to molecular heterogeneity of tumor cells. The B-cell lymphoma 9 (BCL9) oncogene functions as a transcriptional co-activator of the Wnt/β-catenin pathway, which plays critical roles in CRC pathogenesis. Here we have identified a β-catenin-independent function of BCL9 in a poor-prognosis subtype of CRC tumors characterized by expression of stromal and neural associated genes. In response to spontaneous calcium transients or cellular stress, BCL9 is recruited adjacent to the interchromosomal regions, where it stabilizes the mRNA of calcium signaling and neural associated genes by interacting with paraspeckle proteins. BCL9 subsequently promotes tumor progression and remodeling of the tumor microenvironment (TME) by sustaining the calcium transients and neurotransmitter-dependent communication among CRC cells. These data provide additional insights into the role of BCL9 in tumor pathogenesis and point towards additional avenues for therapeutic intervention.

2020-05-27 | PXD016172 | Pride

Elevated PRKD2 Promotes Progression and Poor Prognosis of Multiple Myeloma

Project description:Elevated PRKD2 Promotes Progression and Poor Prognosis of Multiple Myeloma

| PRJNA1117013 | ENA

The lipid-metabolism enzyme ECI2 reduces neutrophil extracellular traps formation for colorectal cancer suppression

Project description:Abnormalities in ether lipid metabolism as well as the formation of neutrophil extracellular traps have recently been recognized as detrimental factors affecting tumorigenesis and progression. However, the role of abnormal ether lipid metabolism in colorectal cancer (CRC) evolution has not been reported. Here we show that the lipid metabolism-related gene enoyl-CoA δ-isomerase 2 (ECI2) plays a tumor-suppressor role in CRC and is negatively associated with poor prognosis in CRC patients. We mechanistically demonstrate that ECI2 reduces ether lipid-mediated Interleukin 8 (IL-8) expression leading to decreased neutrophil recruitment and neutrophil extracellular traps formation for colorectal cancer suppression. In particular, ECI2 inhibits ether lipid production in CRC cells by inhibiting the peroxisomal localization of alkylglycerone phosphate synthase (AGPS), the rate-limiting enzyme for ether lipid synthesis. These findings not only deepen our understanding of the role of metabolic reprogramming and neutrophil interactions in the progression of CRC, but also provide ideas for identifying potential diagnostic markers and therapeutic targets for CRC.

2024-10-01 | MTBLS10323 | MetaboLights

HIGHLY EXPRESSED GENES IN RAPIDLY PROLIFERATING TUMOR CELLS AS NEW TARGETS FOR COLORECTAL CANCER TREATMENT

Project description:The clinical management of colorectal cancer patients has significantly improved due to the identification of new chemotherapeutic targets. Since rapid tumor proliferation is associated with poor patient prognosis, here we characterize the transcriptional signature of rapidly proliferating colorectal cancer cells in an attempt to identify novel candidate therapeutic targets. Therefore, the doubling time of 52 colorectal cancer cell lines was determined and genome-wide expression profiling of a subset of 31 of these cell lines was assessed by microarray analysis.

2015-05-13 | E-MTAB-2971 | biostudies-arrayexpress

Project description:YKT6 Promotes Breast Cancer Progression and Is Associated with Poor Prognosis and Immune Infiltration

| PRJNA1418360 | ENA